AstraGin® is a branded botanical ingredient made from extracts of Panax notoginseng root and Astragalus membranaceus root. It is used in selected nutraceutical and dietary supplement formulations, particularly products developed around nutrient absorption and gastrointestinal function.
The ingredient combines two botanical extracts with distinct phytochemical profiles. Its composition, manufacturing process, and quality specifications are defined by the particular commercial product and should be verified using the current manufacturer's technical documentation.
AstraGin® is a botanical extract blend developed for use in nutraceutical formulations. The botanical material described in the published European safety assessment consists of an ethanol extract of Astragalus membranaceus root and a hot-water extract of Panax notoginseng root. The two extracts are combined with maltodextrin as a carrier.
The resulting ingredient is generally described as a beige to light-brown or yellow powder. Its principal measured constituents include total saponins, ginsenoside Rb1, and astragaloside I.
Panax notoginseng is a plant traditionally used in Asian herbal preparations. Its roots contain saponins, including ginsenosides. Ginsenoside Rb1 is one of the marker compounds used to characterise the extract described in the published specification.
Astragalus membranaceus is a botanical traditionally used in herbal preparations. Its roots contain several naturally occurring constituents, including astragalosides. Astragaloside I is a marker compound specified for the assessed AstraGin™ extract.
The exact botanical identity, extraction method, standardisation, and composition should be confirmed for the commercial product being purchased.
AstraGin® may be considered for formulation development in selected categories, subject to product specifications and local regulatory requirements:
Suitability depends on the formulation, dosage form, intended consumer group, and permitted use in the destination market.
Botanical extracts naturally vary according to plant source, cultivation, extraction, and processing. Standardisation helps establish consistent levels of selected marker compounds.
The published European assessment of the evaluated AstraGin™ extract specifies total saponins, ginsenoside Rb1, and astragaloside I, alongside moisture, ash, protein, contaminant, and microbiological parameters. These values should only be used for a commercial listing after confirming that the supplied product matches the assessed specification.
Before purchasing AstraGin®, request a current technical data sheet and certificate of analysis. Buyers should verify the botanical identity, marker-compound levels, ingredient composition, carrier content, contaminant testing, microbiological results, shelf life, and storage requirements.
Additional documentation may include allergen declarations, country-of-origin information, applicable regulatory statements, and authorised brand or distribution information.
AstraGin®'s regulatory status depends on the country, intended use, product category, and applicable requirements. The European Union has an authorised novel-food entry for the specified botanical extract, with conditions of use for adult food supplements. This does not automatically establish permission for every product format or market.
For products intended for sale in India, confirm the applicable FSSAI requirements before making claims or including the ingredient in a commercial formulation.
Mediocon Inc. can assist with product enquiries and requests for botanical ingredient documentation. Contact the team to confirm availability, commercial supply details, current specifications, and suitability for your intended nutraceutical formulation.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying AstraGin® Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our AstraGin® Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance